Rather than treating ibogaine-related opportunities as a standalone commercial priority, the company appears to be assessing how specialized delivery technologies and intellectual property could complement its existing capabilities in metabolic therapeutics and nontraditional administration
Yao, Tao Zhang, Xian-Tao Zeng, Ji-Hong Feng, Xue Xiao Journal: International immunopharmacology Journal ranking: Q1 Key takeaways: Synthetic thymic peptides, particularly thymosin 1, combined with chemotherapy significantly improve patient quality of life and survival rates in non-small cell lung cancer
Unlike fillers, Botox and Dysport are neuromodulators that relax muscles of the target area
On the other hand, Type 2 diabetes, which accounts for a hefty 90-95% of global diabetes instances, occurs due to a combination of genetic and environmental reasons
Glutathione efficacy soars for immune support (400% NK cell boost) and more